COSCIENS Biopharma Inc.
CSCIF · OTCMCIK 1113423fmd_12PM3P384PFH99P7TJXTW2QFNHManufacturing · Perfumes, Cosmetics & Other Toilet PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 34 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 27 | 1 | 4 | 5 | 15 | 7 | 10 | 7 |
| Cost of revenue | 0 | 0 | 2 | 0 | 2 | 0 | 6 | 4 | 5 | 5 |
| Gross profit | 1 | 1 | 25 | 0 | 1 | 5 | 9 | 3 | 5 | 3 |
| Research and development | 16 | 11 | 3 | 2 | 2 | 7 | 1 | 2 | 8 | 3 |
| Selling, general and administrative | – | – | – | – | – | – | 3 | 6 | 10 | 10 |
| Operating income | (29) | (23) | 10 | (10) | (6) | (9) | 4 | (5) | (18) | (11) |
| Interest expense | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| Income before taxes | (25) | (20) | 10 | (6) | (5) | (8) | 5 | (4) | (15) | (10) |
| Income tax expense | 0 | (3) | 5 | (0) | 0 | (0) | 1 | (1) | 0 | 0 |
| Net income from continuing operations | (25) | (17) | 4 | (6) | (5) | (8) | 3 | (3) | (15) | (10) |
| Net income | (25) | (17) | 4 | (6) | (5) | (8) | 3 | (3) | (15) | (10) |